PCSK9 gene editing therapy (Acuitas Therapeutics/University of Zurich)
N/A
Report date: 2025/03/20 15:26:35
Base Information
Drug NamePCSK9 gene editing therapy (Acuitas Therapeutics/University of Zurich)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcuitas Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesAcuitas Therapeutics IncUniversity of Zurich
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A